A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

Sarcoma, KaposiHIV Infections

Interventions

DRUG

Nelfinavir mesylate

Trial Locations (5)

LAC and USC Med Ctr / School of Medicine, Los Angeles

Harbor - UCLA Med Ctr - Box 449, Torrance

UCSD Treatment Ctr, San Diego

Univ of California / UCI Med Ctr, Orange

Santa Clara Valley Med Ctr, San Jose